TENAX THERAPEUTICS, INC. (TENX)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, TENAX THERAPEUTICS, INC. reported revenue of $0. The company ran a net loss. It held $104.23M in total assets against $7.16M in total liabilities.
Key ratios (FY2025)
-54.2%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — | — | $0 |
| Gross Profit | — | — | — | — | — | — | — | — | — | $0 |
| Operating Income | -$56.38M | -$19.49M | -$8.23M | $11.05M | -$32.73M | $9.87M | -$8.56M | -$6.89M | -$9.21M | -$52.65M |
| Net Income | -$52.60M | -$17.60M | -$7.71M | $11.05M | -$32.47M | -$9.85M | -$8.39M | -$14.14M | -$8.84M | -$43.92M |
| EPS (Diluted) | $-1.34 | $-1.15 | $-31.04 | — | — | — | — | — | — | — |
| Total Assets | $104.23M | $96.69M | $11.69M | $3.40M | $5.99M | $6.87M | $6.37M | $13.34M | $9.89M | $23.34M |
| Total Liabilities | $7.16M | $4.69M | $3.59M | $1.91M | $1.75M | $2.24M | $2.59M | $1.57M | $1.01M | $6.20M |
| Shareholders' Equity | $97.07M | $91.99M | $8.10M | $1.49M | $4.24M | $4.63M | $3.77M | $11.77M | $8.88M | $17.14M |
| Cash & Equivalents | $97.60M | $94.90M | $9.80M | $2.12M | $5.58M | $6.25M | $4.91M | $12.37M | $1.60M | $10.00M |
| Operating Cash Flow | -$35.80M | -$14.81M | -$5.90M | -$11.39M | -$10.86M | -$9.27M | -$7.56M | -$5.50M | -$12.14M | -$15.87M |
| Capital Expenditures | — | — | — | $2.3K | $5.3K | $3.5K | $3.6K | $7.6K | $4.5K | $2.9K |
| Shares Outstanding | 9.31M | 3.42M | 298.3K | 28.6K | 1.26M | 12.62M | 6.74M | 3.79M | 1.41M | 1.41M |